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Abstract
The free radicals are reactive molecules with electron-rich groups produced during 
metabolic reactions occurring in the cells. These free radicals are collectively known as 
reactive oxygen species (ROS) and reactive nitrogen species (RNS). Lipid peroxida-
tion products and protein carbonyls species are under the group of ROS, and nitric 
oxide and peroxynitrites are under the group of RNS. The malondialdehyde that reacts 
with LDL-C indirectly induced the risk of atherosclerosis. The protein carbonyls acts 
as marker of protein oxidation and exerts damage to proteins. The nitric oxide plays an 
important role in DNA damage, inflammation, proliferation of cancer cells, and dys-
function of apoptosis. The peroxynitrites could induce the process of lipid peroxida-
tion, DNA damage, and may exert chronic damage to all biomolecules. The aim of the 
present study is that the free radicals may react with biomolecules of the cells and play 
an important role in the development of chronic disease conditions in the humans.
Keywords: reactive oxygen species, reactive nitrogen species, oxidative stress, 
pathological conditions
1. Introduction
Free radical is a molecule with an unpaired electron and capable of high reactivity 
[1, 2]. Free radicals are found to be involved in alteration of redox system, induced 
DNA damage, activation of procarcinogens, these all markers of induction of cancer 
[3]. Some of the radicals are the superoxide (O−2), hydroxyl (OH∙), alkoxy radical 
(RO∙), and nitric oxide (NO), and nonradical species are hydrogen peroxide (H2O2), 
singlet oxygen (1O2), and peroxynitrites (ONOO▬), which play an important 
role in the development and progression of different pathological conditions [4]. 
NO-induced dose-responsive DNA strand breakage and deaminations of cytosine to 
uracil and 5-methylcytosine to thymine account for the mutagenicity of nitric oxide 
toward bacteria and mammalian cells [5]. Antioxidants are proved that reduce the 
actions of reactive oxygen and nitrogen species, which are capable of damaging cells 
and tissues [6]. The proteins contain nitrotyrosine residues accumulate in cells which 
disrupts multiple regulatory pathways [7].
Nitroxidative stress maker species are actively engaged in the chronic disease com-
plications, and their toxicity is reduced by antioxidants which have protective effects 
[8]. The enzymes of NADPH oxidases, xanthine oxidase, uncoupled nitric oxide 
synthase, and mitochondria act as markers of reactive oxygen species production in 
all metabolic cells [9]. Free radicals thus adversely alter lipids, proteins, and DNA 
and trigger a number of human diseases [10]. Peroxynitrites are the leading molecule 
of reactive nitrogen species by enhancing the process of lipid peroxidation, DNA 
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damage, and protein oxidation and act as molecular target for drug development for 
cardiovascular, inflammatory, and neurodegenerative diseases [11]. In the cells, the 
interaction of excess superoxides with excess nitric oxide results in the generation 
of peroxynitrite which specify the chronic disease conditions of stroke, myocardial 
infarction, chronic heart failure, diabetes, circulatory shock, chronic inflammatory 
diseases, cancer, and neurodegenerative disorders [12]. The reduced glutathione, 
glutathione disulfide, and glutathionylated proteins act as markers of redox imbal-
ance are directly proportional to oxidative stress [13].
The ROS requires oxygen for its formation and play an important role in human 
health and disease [14]. The development of increased ROS production with the 
simultaneous dysfunction of mitochondria has been exhibited in the pathogenesis of 
disorders [15]. Every cell especially vascular cells are involved in the higher produc-
tion of free radicals implicated in the pathogenesis of ischemic heart disease, athero-
sclerosis, cardiac arrhythmia, hypertension, and diabetes [16]. The scavenging role 
of hydrogen peroxide is performed by catalase and decreases catalase activity results 
in aggregation of hydrogen peroxide leads to formation of oxidative distress [17]. The 
aerobic metabolic reactions are faced to greater a concentration of oxygen generates 
and is increased oxidation it leads inflammation, mitochondrial dysfunction, and 
chronic kidney diseases [18]. The purpose of the present review is to investigate the 
role of free radicals in various physiological and pathological diseases like neuro-
disorders, cancer, renal, cardiovascular, and immunological dysfunctions (Figure 1).
2. Oxidation and cancer
The reactive oxygen and nitrogen species (RONS) are synthesized in greater 
concentration by reducing antioxidant defense, and formation of redox imbalance 
leads to oxidative damage to the DNA and proteins in the oral squamous cell carci-
noma [20]. In animals, ROS may influence cell proliferation and cell death through 
the activation of several signaling pathways in the development of carcinogenesis 
[21]. The higher level of ROS is directly proportional to the suppression of antioxi-
dant enzymes and significant role of oxidative-induced injury in the breast cancer 
[22]. The prolonged exposure and intake of tobacco is strongly associated with  
decreased status of antioxidant enzymes, increased oxidative stress markers  
with the pathogenesis of oral cancer [23]. The strong correlations of ROS and RNS 
with lowered antioxidants are found in oral precancer and cancer [2] (Figures 2–3).
Figure 1. 
Impact of free radicals on biomolecules present in cells leads to formation of adducts, markers of various 
diseases [19].
3Diseases Related to Types of Free Radicals
DOI: http://dx.doi.org/10.5772/intechopen.82879
2.1 Free radical cause nitric oxide
The nitric oxide (NO) has dual role in health and disease and depends on its 
concentration. Nitric oxide is the active marker of the development of cancer 
by induction of angiogenesis, blood vessel formation during physiological and 
pathological processes [25]. NO may modulate tumor DNA repair mechanisms by 
upregulating p53, poly (ADP-ribose) polymerase, and DNA-dependent protein 
kinase (DNA-PK). The role of NO in cancer will have profound therapeutic implica-
tions for the diagnosis and treatment of disease [26]. Alterations in the NO metabo-
lism and to increase protein nitration may contribute to the mutagenic processes 
and promote lung carcinogenesis [27]. NO promotes intravasation and angiogenesis 
to enhance cancer cell growth and increase the properties of cancer cells [28].
Figure 2. 
The functions of free radicals on biomolecules and its consequences [24].
Figure 3. 
Reactive oxygen species are involved in the development of various pathological disorders [38].
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In lung cancer, a high level of NO is linked to chronic stages of cancer cells and 
protective role in the survival and proliferation of tumor cells by inhibiting apopto-
sis, increasing cell migration, and invasion [29]. NO and its role in carcinogenesis and 
tumor progression, as well as dietary chemopreventive agents have NO-modulating 
properties with safe cytotoxic profile [30]. The nitric oxide synthase 2-mediated 
production of NO/reactive nitrogen oxide species (RNS) is heavily involved in cancer 
progression and metastasis in different types of tumor (Figure 4) [31].
2.2 Free radical cause peroxynitrites
Peroxynitrites (ONOO▬) could able to cause DNA strand breaks and oxidize 
cellular thiol groups in viable rat thymocytes in a dose-dependent fashion [32]. 
ONOO▬ is actively involved in the disturbances of signaling pathways of epider-
mal growth factors indirectly induced the process of tumorigenesis [33]. The com-
bined effects of nitric oxide and oxidized LDL forms increase the concentrations 
of peroxynitrites that leads to glutathionylation of p21 ras proteins which results in 
aberrant activation of p21 [34]. The S-nitrosylation of PTEN, Bcl2 enhanced DNA 
mutation, and inhibition of apoptosis results in cell proliferation and cell survival 
[35]. The peroxynitrite could modify the DNA and increase the DNA adducts which 
act as antigens is one of the factors for the autoantibody induction in cancer patients 
[36]. Levels of peroxynitrite and nitrosylhemoglobin can be used as highly informa-
tive markers of disease prognosis and therapeutic approach [37].
2.3 Free radical cause lipid peroxidation
Lipids are major structural components of the membranes and are highly 
addictable to oxidation by the presence of reactive double bonds [39]. The malondi-
aldehyde (MDA), product of lipid peroxidation, reacts with low-density lipopro-
teins and indirectly induced the process of atherosclerosis [40]. The high level of 
oxidative stress is directly proportional to progression of tumor stages in lungs and 
pulmonary parenchyma [41]. The lipid peroxides are one of the ROS that enhance 
the DNA damage through mutations which results in decreased expression of tumor 
suppressor genes or increased expression of oncogenes [42]. ONOO▬ is the initiator 
of induction of lipid peroxidation which disrupts the membranes and lipoproteins. 
Figure 4. 
The role of nitric oxide in various diseases of humans [57].
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These ONOO▬ and MDA collectively act as cytotoxic as well as mutagenic in cancer 
progression [43]. The formation of oxidative stress due to imbalance of redox system 
in the cells through increased lipid peroxidation has been associated with human 
health and diseases, including cancer [44]. The lower levels of cholesterol was 
detected in cancer cells and suspectible to attack of free radicals enabling the pen-
etration of RONS into the interior of the cell, inducing pro-apoptotic factors [45].
3. Neurodegenerative diseases
3.1 Free radical cause peroxynitrites
The combined effects of peroxynitrite and sulfur-containing amino acids have been 
implicated in Parkinson’s disease by performing the synergistic toxicity to a neuronal 
cell line [46]. The protein nitration in the form of nitrotyrosine residues is by the actions 
of peroxynitrite. Increased concentrations of both protein carbonyls and 3-nitrotyrosine 
have been reported in various neurodegenerative diseases like Alzheimer’s disease (AD), 
Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) [47]. The decreased 
activity of antioxidant enzymes with the simultaneous increase in the concentrations of 
peroxynitrites leads to disturbances of oxidative phosphorylation was observed in the 
brain mitochondria [48]. The modification of the monomers, destabilize microtubules, 
and major alterations in neurodegenerative diseases is performed by peroxynitrites [49]. 
The effects of S-nitrosylation on neuronal excitation are due to stimulation of ionotropic 
glutamate receptors and toxic Aβ peptides in Alzheimer’s disease [50].
3.2 Free radical cause nitric oxide
In the lower doses, nitric oxide acts as a neurotransmitter of the neuronal 
cells, and it exerts antimicrobial activity invading microbes in macrophages [51]. 
Nitric oxide played an important role in the modulation of CO2-mediated cerebral 
blood flow [52]. Nitric oxide is a physiological signaling molecule produced from 
L-arginine by enzyme of nitric oxide synthase (NOS). This enzyme occurs in three 
forms as neuronal (nNOS), endothelial (eNOS), and inducible nitric oxide synthase 
(iNOS). It increases the cGMP levels by acting as vasodilator and is involved in the 
neurotransmission between nervous system cells [53]. The positive association of 
oxidative stress and neurodegenerative conditions was observed in multiple scle-
rosis, stroke, and neurodegenerative disorders [54]. The ROS is actively involved in 
the oxidative damage to amyloid beta peptides, marker in the Alzheimer’s disease 
[55]. The most abundant neurotransmitter in central nervous system is glutamate 
which acts as the initiator of NO formation, and H2S is highly expressed in brain 
which is involved in the pathogenesis of various neurological disorders [56].
3.3 Free radical cause lipid peroxidation
The brain oxidative damage contributes to AD pathogenesis by the Aβ accu-
mulation and amyloid plaque formation in the Alzheimer’s disease of Tg2576 
mice [58]. The imbalance of functioning endogenous antioxidant system leads to 
accumulation of free radicals, which not only induces the process of lipid peroxi-
dation but also plays a central role in neurodegeneration [59]. Lipids are critical 
for plasticity and function of neuronal development. The abnormalities in lipid 
metabolism contribute to the pathogenesis of several neurodegenerative disorders 
like Alzheimer’s disease and Parkinson’s disease [60]. The relationship between lipid 
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alterations in energy metabolism and mitochondrial dysfunction in neurodegenera-
tive disorders [61]. Deposition of abnormal aggregated proteins and disruption of 
metal ion homeostasis are highly associated with oxidative stress [62]. The antiox-
dant and free radicals of lipid peroxidation and cognition, and cognitive response 
to an exercise intervention program, in adults with coronary artery disease at risk 
of dementia [63]. The brain is more susceptible to lipid peroxidation due to its high 
oxygen consumption, high level of redox metal ions, reduced antioxidant defense 
mechanism, and high level of polyunsaturated fatty acids [64].
4. Cardiovascular diseases
4.1 Free radical cause nitric oxide
Decreased concentrations of nitric oxide may cause constriction of coronary arter-
ies and contribute to provocation of myocardial ischemia in coronary artery disease 
patients. The nitric oxide present in lower amounts exerted the vascular inflamma-
tion that could lead to oxidation of lipoproteins and foam cell formation that leads to 
the development of the atherosclerotic plaque [65]. These ROS actively involved in 
atherogenesis through their formation from enzymes of xanthine oxidase, nicotin-
amide adenine dinucleotide phosphate (NADPH) oxidases, and nitric oxide synthase 
[66]. The peroxynitrites directly increases sarco/endoplasmic reticulum calcium (Ca2+ 
ATPase) sarco/endoplasmic reticulum calcium (SERCA) activity by S-glutathiolation 
and irreversible oxidation of the relevant cysteine thiols in atherosclerosis [67]. An 
imbalance of reduced production of NO or increased production of superoxide results 
in the endothelial dysfunction [68].
The dual role is performed by the nitric oxide NO in the cells, and at low con-
centrations, it regulates normal protective functions, but at high concentration may 
contribute to the pathogenesis [69]. Oxidative stress, mitochondrial dysfunction, 
and stress-related cell death pathways (apoptosis and necrosis) are related to the 
improper functioning of cardiovascular system [70]. Most ROS that are generated 
as by-products during mitochondrial electron transport and reactive nitrogen 
species (RNS) are peroxynitrites and nitric oxide, contributing to the role in the 
development of cardiovascular disease [71]. The specific markers of ROS are altered 
to inflammation that enhanced the risk of atherosclerosis by diabetes [72]. The 
vasodilator activity of NO may be unique among therapeutic options for manage-
ment of hypertension, renal disease, and left ventricular hypertrophy [73].
4.2 Free radical cause peroxynitrites
Nitric oxide is important physiological signaling molecule also known as the  
endothelial-derived-relaxing factor (EDRF), and can form free radicals like 
peroxynitrites capable of peroxidizing the LDL and proteins [74]. Formation of 
peroxynitrite is augmented in inflammatory-like conditions such as ischemia-reper-
fusion injury in the high dose manner [75]. Proinflammatory cytokines stimulate 
the concerted enhancement in superoxide and NO-generating activities in the heart 
and causes myocardial contractile failure [76]. The protein nitration and inactiva-
tion of creatine kinase during heart failure in cardiac muscles are performed by 
peroxynitrites [77].
Peroxynitrite depresses myocardial contractility by decreasing the ability of 
Ca2+ to trigger contraction through cGMP/cGMP-dependent protein kinase path-
way [78]. The peroxynitrite exposure results in reduced sarcoplasmic reticulum 
(SR) Ca2+-ATPase (SERCA2a isoform) activity is a major determinant of reduced 
7Diseases Related to Types of Free Radicals
DOI: http://dx.doi.org/10.5772/intechopen.82879
contractility in heart failure [79]. Peroxynitrites that are present in higher concen-
trations depicts a crucial pathogenic mechanism of stroke, myocardial infarction, 
chronic heart failure, diabetes, circulatory shock, chronic inflammatory diseases, 
cancer, and neurodegenerative disorders [12]. The synergistic performance of nitric 
oxide, superoxides, peroxynitrites are effect on mitochondrial function and cell 
death [80].
4.3 Free radical cause lipid peroxidation
Abnormalities in levels of antioxidants like GSH are associated to accumulation of 
lipid peroxidation in chronic heart failure [81]. Increased formation of lipid perox-
ides and aldehydes has been observed in atherosclerosis, ischemia-reperfusion, and 
heart failure [82]. Atherosclerosis, the hardening of arteries under oxidative stress 
is related to oxidative changes of low density lipoproteins (LDL) which is an early 
prediction of development of cardiovascular disease [83]. The proinflammatory 
effects that result from the peroxidation of lipids, which provide critical structure 
and function in cellular membranes, are the main sites of pollutant attack in cardio-
vascular diseases of atherosclerosis, arrhythmia, hypertension, and stroke [84].
5. Immunological disorders
5.1 Free radical cause nitric oxide
Peroxynitrite converts low density lipoprotein to a form recognized by the mac-
rophage scavenger receptor and that this process is associated with modification of 
the protein and lipid, and with the oxidation of alpha-tocopherol to alpha-tocoph-
erol quinine [85]. The activated macrophages are involved in the production of large 
amounts of nitric oxide and indirectly diminish lymphocyte proliferation [86]. 
Tyrosine nitration is recognized as a prevalent and significant post-translational  
protein modification that serves as an indicator of nitric oxide-mediated oxidative 
inflammatory reactions [87]. Prolonged iNOS expression peroxynitrite may exac-
erbate inflammatory responses mediated by NF-kappaB due to prolonged inducible 
nitric oxide synthase [88].
NO regulates the structural and functional activity of many immune and 
inflammatory cells like macrophages, T lymphocytes, antigen-presenting cells, mast 
cells, neutrophils, and natural killer cells [89]. The proinflammatory nature of NO 
is actively involved in the process of inflammation only at higher concentrations 
[90]. The macrophages in active state are actively engaged in the production of 
not only NO production but also TNFα production [91]. Stimulatory effects of NO 
on integrin β1 expression and Talin phosphorylation were mediated by the cGMP 
signaling pathway, which is likely involved in wound healing [92].
5.2 Free radical cause peroxynitrites
Physiological role for ONOO▬ as a down-modulator of immune responses and 
also as key mediator in cellular and tissue injury is associated with chronic activa-
tion of the immune system [93]. In chronic inflammatory diseases, peroxynitrite 
formed by phagocytic cells may cause damage to DNA which acts as epitopes for the 
production of autoantibodies [94]. The central role of peroxynitrite is performed 
in the control of infections in macrophages [95]. They are produced throughout 
the vascular system, regulate differentiation and contractility of vascular smooth 
muscle cells, control vascular endothelial cell proliferation and migration, mediate 
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platelet activation and hemostasis, and significantly contribute to the immune 
response [96]. Elevated reactive oxygen and nitrogen species are reduced levels of 
glutathione with chronic systemic inflammation with elevated levels of pro-inflam-
matory cytokines [97]. The ONOO▬ could be modified by the histone proteins 
that lead to formation of oxidatively nitrated histones in the initiation and progres-
sion of autoimmune inflammatory diseases [98]. Peroxynitrite represents both a 
pathophysiologically relevant endogenous cytotoxin and a cytotoxic effector against 
invading pathogens [99]. Being a mediator of protein oxidation and nitration, lipid 
peroxidation, mitochondrial dysfunction, and cell death, peroxynitrite represents 
both a pathophysiologically relevant endogenous cytotoxin and a cytotoxic effector 
against invading pathogens [99].
5.3 Free radical cause lipid peroxidation
Plasma malondialdehyde and glutathione levels have been used as a determinate 
of oxidative status in the chronic immunological disorders; systemic lupus  
erythematosus (SLE) is a complex [100]. 4-Oxo-2-nonenal (ONE) is a highly 
reactive aldehyde originating from the peroxidation of polyunsaturated fatty acids 
involved in the pathogenesis of autoimmune disorders [101]. The product of lipid 
peroxidation is 4-hydroxynonenal (HNE) that acts as specific marker of immunose-
nescence and aging-related disorders [102].
6. Renal diseases
6.1 Free radical cause peroxynitrites
Ischemia-reperfusion injury showed decreased levels of 3-nitrotyrosine-protein 
adducts. The iNOS-generated NO mediates damage in I-R injury possibly through 
ONOO▬ formation [103]. Patients with chronic renal failure (CRF) showed 
decreased endothelium-dependent vasodilatation to acetylcholine, have increased 
markers of oxidative stress, and diminished antioxidant activity [104]. ONOO▬ 
could induce entire mitochondrial protein nitration, responsible for the damage 
of renal mitochondria in diabetes [105]. Nitrosative stress is involved in cisplatin-
induced nephrotoxicity in rats through peroxynitrite-induced nephrotoxicity and 
protein nitration [106]. Renal hypoxia and ischemia promotes the formation of 
reactive oxygen species (ROS) such as superoxide radical anions, peroxides, and 
hydroxyl radicals, that can oxidatively damage biomolecules and membranes, and 
affect organelle function and induce renal tubule cell injury, inflammation,  
and vascular dysfunction [107].
6.2 Free radical cause nitric oxide
The rate of whole body NO synthesis was increased in the end stage renal disease 
(ESRD) patients [108]. In several animal models of renal disease, the increase in 
NO synthesis is associated with reduced degree of glomerulosclerosis, infiltration 
of the kidney by invading macrophages [109]. The relations between endothelial 
and inducible nitric oxide synthases are perturbed in renal ischemia primarily as 
a result of endothelial dysfunction [110]. The nitric oxide is highly reactive and 
exerts its chronic effects only at high concentrations which are responsible for the 
complications of dialysis of patients with chronic kidney disease [111]. Patients with 
chronic kidney disease (CKD) have been found the decreased levels in all stages of 
CKD [112]. Intracellular nitric oxide (iNO) substantially increased the risk of renal 
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dysfunction in patients with acute respiratory distress syndrome (ARDS) [113]. The 
process of oxidative stress affects kidney function by elevated the damage in renal 
vessels, glomeruli, and tubules [114]. In patients with multiple valve replacement 
and prolonged cardiopulmonary bypass, administration of nitric oxide decreased 
the incidence of acute kidney injury [115].
7. Some other type of free radicals
7.1 Hydroxyl radicals
It is the most reactive of the free radical molecules. It damages cell membranes 
and lipoproteins by lipid peroxidation. Damage to lipoproteins in low density 
lipoprotein plays an important role in atherosclerosis. ∙OH is formed by radiolysis of 
water and by reaction of H2O2 with ferrous (Fe2+) ions; the latter process is termed 
as Fenton reaction [116, 117]. The reactive oxygen species, hydroxyl (∙OH) radical 
is one of the potential inducers of DNA damage. A variety of adducts are formed on 
reaction of ∙OH radical with DNA. The ∙OH radical can attack purine and pyrimi-
dine bases to form ∙OH radical adducts, which are both oxidizing and reducing 
in nature which in turn can induce base modifications and sometimes release of 
bases. Some of the important base modifications include 8-hydroxydeoxyguanosine 
(8-OHdG), 8 (or 4-,5-)-hydroxyadenine, thymine peroxide, thymine glycols, and 
5-(hydroxymethyl) uracil [118].
7.2 Free radical cause lipid peroxidation
Lipids that contain phosphate groups (i.e., phospholipids) are essential 
components of the membranes that surround the cells and cell structures. Free 
radicals in the presence of oxygen may cause degradation (peroxidation) of lipids 
within plasma and organellar membranes. Oxidative damage is initiated when the 
double bonds in unsaturated fatty acids of membrane lipids are attacked by oxygen 
derived free radicals particularly by OH. The lipid free radical interactions yield 
peroxides, which are themselves unstable and reactive, and an autocatalytic chain 
reaction called propagation ensues which can result in extensive membrane, organ-
ellar, and cellular damage [116, 119]. Oxidative destruction of polyunsaturated 
fatty acids by lipid peroxidation is damaging because it may alter the integrity of 
cell membranes. [120].
7.3 Superoxide oxygen (O2∙—one electron)
It is generated by direct auto-oxidation of O2 during mitochondrial electron 
transport reaction. Alternatively, O2∙ is produced enzymatically by xanthine 
oxidase and cytochrome P450 in the mitochondria or cytosol [121]. O2∙ so formed 
is catabolized to produce H2O2 by superoxide dismutase (SOD), a metalloprotein. It 
is considered to be the least reactive type of ROS and the most commonly produced 
free radical in humans. Once it is produced, it triggers a rapid cascade of events that 
creates other free radicals.
7.4 Singlet oxygen
Singlet oxygen (1O2) is an electronically excited form of oxygen which is well 
known to be formed when photosensitizers such as chlorophyll or the aromatic dye 
rose Bengal absorb light energy and transfer some of that energy to molecular oxygen 
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[122, 123]. Various nonphotosensitized mechanisms for its formation have also been 
reported and suggested to occur in biological systems, but the importance of such 
endogenous singlet oxygen formation has had a controversial history [122, 124]. 
Ozone (O3) is best known as occurring in the stratosphere where it shields organisms 
on earth from ultraviolet C and much of ultraviolet B radiations, which are the most 
damaging UV components of solar radiations because they are readily absorbed 
by DNA [125, 126]. It is also known as a respiratory system-damaging pollutant in 
the troposphere and ironically as a therapeutic agent in alternative medicine [127]. 
More recently, it was shown that antibodies or amino acids catalyze the conversion 
of singlet oxygen (1O2) to ozone (O3) and that this reaction occurs during the killing 
of bacteria by activated neutrophils [128, 129]. Since both singlet oxygen and ozone 
are highly reactive oxygen species, a full understanding of their mechanisms of 
formation and action in vivo is necessary. Hence, various reported mechanisms of the 
endogenous formation of these reactive oxygen species (ROS), the potential rel-
evance of such pathways in human physiology, diseases and activity of these oxidants.
8. Conclusions
The free radicals are normally synthesized during metabolic reactions in the 
cells and disease. These free radicals are removed by various scavenging activities 
of cellular and noncellular antioxidants. The imbalance of excess ROS formation 
and diminished activity of antioxidants results in the formation of oxidative stress 
which is linked with various pathological chronic conditions like cardiovascular, 
neurodegenerative, and renal disorders.
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